To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

June 22, 2023

2023 Hope Award Runner Up

Jenn and her husband with hope award logo

Jenn Ortiz is a fighter, according to the Ivy Center Communications Specialist, Jennifer Keeler, who nominated her for the Hope Award. “When she was first diagnosed with Glioblastoma and learned she may have only 12- 15 months to live, she allowed one tear to roll down her cheek, then said, ‘No, not me.’ She was determined to beat it. When her brain tumor returned two years later, she was even more resolved to fight it. She enrolled in a clinical trial and began experimental treatment. Today, almost three years later, Jenn is healthy and filled with hope for the future. She’s focused on her future.”

Jennifer’s hope: “I’m going to save ME and everyone after me. My husband Matthew hates when I say this, but I believe that Glioblastoma has been a blessing; I have been provided opportunities and time with my family I never had before. I’m home to take my young son to his activities. I get to participate in hobbies I never had time for, and I can make my mind, body, and soul a priority.” She and her husband go dancing every Saturday night.

Each May, for the past 10 years, the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE award to many brain cancer patients who deeply inspire us with their courage and story. We established this award to highlight exceptional people who have done exceptional things during their brain cancer journey all while inspiring others.

This Disease Education, Awareness & Outreach Campaign/ Initiative is made possible by our Sponsors...

Novocure and Imvax logos


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram